Unlock powerful
patient-led collaboration.

Medication drop off and discontinuation are not only challenges for the life sciences industry, it can have a huge impact on disease control and patient outcomes. merakoi works with Patient Experts to understand the “why”, and to co-design solutions that help to inform and support patients through their treatment journey.

Many life sciences and digital health companies struggle with clinical trial recruitment and retention. By working early in the clinical development phase with our Patient Expert Panels, companies can design better studies, more meaningful ePROs, and communication plans  that will drive better recruitment and retention throughout the study.

All too often, we have heard how internal stakeholders do not see the true value of patient collaboration. Although there are many reasons for this, we have found that aligning key stakeholders at the beginning of a project, identifying what a successful outcome would be, and clearly communicating that to our Patient Experts, means we can deliver real value to clients and partners.

We have heard from many Patient Experts how people living in rural areas or certain geographies, those with different ethnic backgrounds or even certain disabilities have difficulty accessing treatment, information and support. By bringing those voices into projects through Patient Experts and their communities, we can identify and address unmet needs of patients.

Too often, companies create digital solutions for patients and then face the immense challenge of recruitment and retention. By collaborating with Patient Experts (and healthcare professionals) throughout the development process, we can help you address obstacles and barriers, and co-design value propositions that speak to prescribers and patients - reducing the risk around your solution and making a business case that also appeals to investors and payers alike!